Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 3(65), 2021
DOI: 10.1128/aac.02422-20
Links
Tools
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
Journal article published in 2020 by
Hang Su,
Xiaohua Ye,
Daniel C. Freed,
Leike Li,
Zhiqiang Ku 
,
Wei Xiong,
Peng Gao,
Xinli Liu,
Diana Montgomery,
Weifeng Xu,
Amy S. Espeseth,
Dai Wang ,
Ningning Ma,
Tong-Ming Fu,
Ningyan Zhang
and other authors.
,
Wei Xiong,
Peng Gao,
Xinli Liu,
Diana Montgomery,
Weifeng Xu,
Amy S. Espeseth,
Dai Wang ,
Ningning Ma,
Tong-Ming Fu,
Ningyan Zhang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Human cytomegalovirus (HCMV) is a ubiquitous pathogen that can cause developmental disorders following congenital infection and life-threatening complications among transplant patients. Potent neutralizing monoclonal antibodies (MAbs) are promising drug candidates against HCMV infection.